维力医疗
(603309)
| 流通市值：34.64亿 | | | 总市值：34.89亿 |
| 流通股本：2.91亿 | | | 总股本：2.93亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 309,185,113.48 | 1,387,735,351.81 | 977,117,684.48 | 651,990,274.92 |
| 营业收入 | 309,185,113.48 | 1,387,735,351.81 | 977,117,684.48 | 651,990,274.92 |
| 二、营业总成本 | 248,108,389.65 | 1,158,743,225.7 | 811,196,360.68 | 538,101,339.09 |
| 营业成本 | 163,876,246.23 | 750,921,388.89 | 533,573,798.76 | 352,446,567.56 |
| 税金及附加 | 4,048,164.89 | 15,809,677.91 | 11,468,712.95 | 7,769,103.15 |
| 销售费用 | 29,847,787.18 | 158,426,580.39 | 108,811,492.06 | 75,244,292.28 |
| 管理费用 | 29,601,745.93 | 133,632,214.35 | 91,771,171.6 | 60,639,062.23 |
| 研发费用 | 20,475,295.9 | 94,921,846.1 | 62,745,219.53 | 41,148,086.2 |
| 财务费用 | 259,149.52 | 5,031,518.06 | 2,825,965.78 | 854,227.67 |
| 其中:利息费用 | 2,038,233.22 | 9,123,609.1 | 5,434,078.34 | 3,370,950.74 |
| 其中:利息收入 | 974,798.31 | 3,670,076.12 | 2,213,109.31 | 1,214,433.87 |
| 加:公允价值变动收益 | 433,118.74 | 76,156.88 | 1,963,080.84 | 1,610,759.53 |
| 加:投资收益 | 1,487,997.39 | 8,532,343.48 | 5,345,989.21 | 4,273,138 |
| 资产处置收益 | 12,275.42 | 94,625.48 | -6,924.58 | - |
| 资产减值损失(新) | -2,389,081.7 | -11,715,828.01 | -1,474,586.34 | -1,229,096.28 |
| 信用减值损失(新) | 436,642.37 | -39,109.76 | 780,468.25 | 125,131.56 |
| 其他收益 | 1,881,524.36 | 12,898,706.76 | 7,198,129.81 | 5,302,326.82 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 62,939,200.41 | 238,839,020.94 | 179,727,480.99 | 123,971,195.46 |
| 加:营业外收入 | 172,977.52 | 294,397.13 | 298,906.17 | 128,734.41 |
| 减:营业外支出 | 214,425.27 | 1,830,674.24 | 1,268,897.81 | 512,842.41 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 62,897,752.66 | 237,302,743.83 | 178,757,489.35 | 123,587,087.46 |
| 减:所得税费用 | 10,347,324.06 | 32,699,638.54 | 26,851,174.88 | 23,512,182.05 |
| 六、净利润 | 52,550,428.6 | 204,603,105.29 | 151,906,314.47 | 100,074,905.41 |
| 持续经营净利润 | 52,550,428.6 | 204,603,105.29 | 151,906,314.47 | 100,074,905.41 |
| 归属于母公司股东的净利润 | 50,255,959.75 | 192,485,118.47 | 143,918,861.68 | 92,081,553.52 |
| 少数股东损益 | 2,294,468.85 | 12,117,986.82 | 7,987,452.79 | 7,993,351.89 |
| (一)基本每股收益 | 0.17 | 0.66 | 0.49 | 0.31 |
| (二)稀释每股收益 | 0.17 | 0.66 | 0.49 | 0.31 |
| 八、其他综合收益 | - | -4,692,888.83 | - | - |
| 归属于母公司股东的其他综合收益 | - | -4,692,888.83 | - | - |
| 九、综合收益总额 | 52,550,428.6 | 199,910,216.46 | 151,906,314.47 | 100,074,905.41 |
| 归属于母公司股东的综合收益总额 | 50,255,959.75 | 187,792,229.64 | 143,918,861.68 | 92,081,553.52 |
| 归属于少数股东的综合收益总额 | 2,294,468.85 | 12,117,986.82 | 7,987,452.79 | 7,993,351.89 |
| 公告日期 | 2024-04-19 | 2024-04-19 | 2023-10-18 | 2023-08-09 |
| 审计意见(境内) | | 标准无保留意见 | | |